Skip to main content
Steve Nolan, left, who manages many ORNL facilities for United Cleanup Oak Ridge, and Carl Dukes worked closely together to accommodate bringing members of the public into the Oak Ridge Reservation to collect distant images from overhead for the BRIAR biometric recognition project. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Carl Dukes’ career as an adept communicator got off to a slow start: He was about 5 years old when he spoke for the first time. “I’ve been making up for lost time ever since,” joked Dukes, a technical professional at the Department of Energy’s Oak Ridge National Laboratory.

Bob Bolton has spent much of his career studying environmental change in Alaska. He recently moved to East Tennessee to join the ORNL-led NGEE Arctic project as deputy for operations. Credit: Carlos Jones/ORNL, U.S. Dept. of Energy

Bob Bolton may have moved to a southerly latitude at ORNL, but he is still stewarding scientific exploration in the Arctic, along with a project that helps amplify the voices of Alaskans who reside in a landscape on the front lines of climate change.

Safari photo illustration

ORNL has launched a new entrepreneurial start-up program, Safari, as an addition to DOE's Office of Technology Transitions Practices to Accelerate the Commercialization of Technologies program. Safari seeks to connect post-exit entrepreneurs with commercially relevant technologies developed by world-leading scientific experts, which could provide the basis for a new business.

Oak Ridge National Laboratory entrance sign

The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.

A new nanoscience study led by an ORNL quantum researcher takes a big-picture look at how scientists study materials at the smallest scales. Credit: Getty Images

A new nanoscience study led by a researcher at ORNL takes a big-picture look at how scientists study materials at the smallest scales.

Madhavi Martin portrait image

Madhavi Martin brings a physicist’s tools and perspective to biological and environmental research at the Department of Energy’s Oak Ridge National Laboratory, supporting advances in bioenergy, soil carbon storage and environmental monitoring, and even helping solve a murder mystery.

ZEISS Head of Additive Manufacturing Technology Claus Hermannstaedter, left, and ORNL Interim Associate Laboratory Director for Energy Science and Technology Rick Raines sign a licensing agreement that allows ORNL’s machine-learning algorithm, Simurgh, to be used for rapid evaluations of 3D-printed components with industrial X-ray computed tomography, or CT. Using machine learning in CT scanning is expected to reduce the time and cost of inspections of 3D-printed parts by more than ten times.

A licensing agreement between the Department of Energy’s Oak Ridge National Laboratory and research partner ZEISS will enable industrial X-ray computed tomography, or CT, to perform rapid evaluations of 3D-printed components using ORNL’s machine

Mike Huettel

Mike Huettel is a cyber technical professional. He also recently completed the 6-month Cyber Warfare Technician course for the United States Army, where he learned technical and tactical proficiency leadership in operations throughout the cyber domain.

The OpeN-AM experimental platform, installed at the VULCAN instrument, features a robotic arm that prints layers of molten metal to create complex shapes. Credit: Jill Hemman/ORNL, U.S Dept. of Energy

Technologies developed by researchers at ORNL have received six 2023 R&D 100 Awards.  

Neutron experiments helped reveal the one-carbon enzymatic mechanism that synthesizes vital food sources for cancer cells that depend on vitamin B6, providing key insights into designing novel drugs to slow the spread of aggressive cancers. Credit: Jill Hemman/ORNL, U.S. Dept. of Energy

After a highly lauded research campaign that successfully redesigned a hepatitis C drug into one of the leading drug treatments for COVID-19, scientists at ORNL are now turning their drug design approach toward cancer.